Vineet Laboratories (VINEETLAB) | Financial Analysis & Statements
Vineet Laboratories Ltd. Small-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
174.2M
Gross Profit
56.0M
32.17%
Operating Income
25.5M
14.64%
Net Income
4.0M
2.30%
EPS (Diluted)
₹0.36
Balance Sheet Metrics
Total Assets
885.4M
Total Liabilities
747.2M
Shareholders Equity
138.2M
Debt to Equity
5.41
Cash Flow Metrics
Operating Cash Flow
-59.9M
Free Cash Flow
154.7M
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Vineet Laboratories Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 750.0M | 1.5B | 2.1B | 1.9B | 2.4B |
| Cost of Goods Sold | 719.1M | 1.2B | 1.8B | 1.6B | 2.1B |
| Gross Profit | 30.8M | 337.1M | 357.5M | 318.0M | 306.8M |
| Gross Margin % | 4.1% | 22.4% | 16.8% | 16.6% | 12.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 21.6M | 34.9M | 40.4M | 24.0M | 6.5M |
| Other Operating Expenses | 80.8M | 120.3M | 122.5M | 115.7M | 110.9M |
| Total Operating Expenses | 102.4M | 155.1M | 162.9M | 139.7M | 117.5M |
| Operating Income | -187.8M | 46.8M | 56.3M | 111.5M | 63.4M |
| Operating Margin % | -25.0% | 3.1% | 2.7% | 5.8% | 2.6% |
| Non-Operating Items | |||||
| Interest Income | 0 | 354.0K | 1.2M | 1.6M | 462.0K |
| Interest Expense | 38.3M | 38.5M | 26.6M | 14.9M | 20.6M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -207.8M | 3.6M | 20.3M | 93.5M | 40.6M |
| Income Tax | -5.8M | -6.6M | 7.8M | 27.1M | 22.8M |
| Effective Tax Rate % | 0.0% | -182.6% | 38.3% | 29.0% | 56.1% |
| Net Income | -201.9M | 10.3M | 12.5M | 66.4M | 17.8M |
| Net Margin % | -26.9% | 0.7% | 0.6% | 3.5% | 0.7% |
| Key Metrics | |||||
| EBITDA | -163.7M | 63.7M | 70.6M | 128.5M | 79.2M |
| EPS (Basic) | ₹-18.40 | ₹1.11 | ₹1.36 | ₹7.16 | ₹1.93 |
| EPS (Diluted) | ₹-18.40 | ₹1.11 | ₹1.36 | ₹7.16 | ₹1.93 |
| Basic Shares Outstanding | 10971389 | 9219008 | 9219008 | 9219008 | 9219008 |
| Diluted Shares Outstanding | 10971389 | 9219008 | 9219008 | 9219008 | 9219008 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Vineet Laboratories Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 3.1M | 2.3M | 6.3M | 166.6M | 7.5M |
| Short-term Investments | 3.6M | 2.7M | 3.2M | 14.6M | 13.5M |
| Accounts Receivable | 132.5M | 316.0M | 351.6M | 362.0M | 427.1M |
| Inventory | 499.7M | 493.9M | 461.7M | 435.4M | 396.9M |
| Other Current Assets | 1.7M | 1.7M | 1.7M | 48.7M | -1.0K |
| Total Current Assets | 673.9M | 881.9M | 874.6M | 1.0B | 863.6M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 18.3M | 18.3M | 18.1M | 18.0M | 17.6M |
| Goodwill | - | - | - | 0 | 0 |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | 0 | 0 |
| Other Non-Current Assets | 6.7M | 1.7M | 3.1M | 4.7M | - |
| Total Non-Current Assets | 271.5M | 286.8M | 283.9M | 306.1M | 223.8M |
| Total Assets | 945.4M | 1.2B | 1.2B | 1.3B | 1.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 336.1M | 322.6M | 348.9M | 600.9M | 559.9M |
| Short-term Debt | 362.6M | 404.1M | 262.4M | 289.8M | 149.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 40.3M | 23.3M | 1.0K | -1.0K | - |
| Total Current Liabilities | 743.9M | 760.0M | 745.1M | 947.7M | 746.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 37.9M | 38.9M | 48.5M | 17.2M | 34.7M |
| Deferred Tax Liabilities | 9.1M | 14.6M | 20.5M | 17.9M | 22.7M |
| Other Non-Current Liabilities | - | 2.0K | - | -1.0K | -2.0K |
| Total Non-Current Liabilities | 55.0M | 61.5M | 76.6M | 53.3M | 74.8M |
| Total Liabilities | 798.9M | 821.5M | 821.7M | 1.0B | 821.3M |
| Equity | |||||
| Common Stock | 92.2M | 92.2M | 92.2M | 92.2M | 92.2M |
| Retained Earnings | -59.2M | 142.7M | 132.4M | 129.1M | 63.1M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 146.5M | 347.2M | 336.8M | 332.2M | 266.2M |
| Key Metrics | |||||
| Total Debt | 400.5M | 443.0M | 310.9M | 307.0M | 184.1M |
| Working Capital | -70.0M | 121.9M | 129.5M | 79.4M | 117.1M |
Balance Sheet Composition
Vineet Laboratories Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -207.8M | 3.6M | 20.3M | 93.5M | 40.6M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | 0 | 0 |
| Working Capital Changes | 224.7M | -110.7M | 114.5M | -84.8M | -765.6M |
| Operating Cash Flow | 76.6M | -86.5M | 167.4M | 27.5M | -698.8M |
| Investing Activities | |||||
| Capital Expenditures | -10.5M | -2.3M | -76.3M | 0 | 0 |
| Acquisitions | - | - | - | 0 | 0 |
| Investment Purchases | - | - | 0 | -38.4M | -78.5M |
| Investment Sales | - | - | 8.3M | 0 | 0 |
| Investing Cash Flow | -12.0M | -1.3M | -68.1M | -38.4M | -78.5M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | 0 | 0 |
| Dividends Paid | - | - | -9.2M | - | - |
| Debt Issuance | 2.0M | 51.9M | 41.7M | 140.4M | 124.7M |
| Debt Repayment | -44.5M | -58.7M | 0 | 0 | 0 |
| Financing Cash Flow | -80.7M | 132.1M | 36.5M | 140.4M | 212.8M |
| Free Cash Flow | 104.5M | -116.6M | -172.5M | 76.3M | -87.1M |
| Net Change in Cash | -16.1M | 44.3M | 135.8M | 129.5M | -564.5M |
Cash Flow Trend
Vineet Laboratories Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
316.25
Price to Book
2.62
Price to Sales
1.37
PEG Ratio
-2.69
Profitability Ratios
Profit Margin
-18.10%
Operating Margin
12.19%
Return on Equity
-137.85%
Return on Assets
-21.36%
Financial Health
Current Ratio
0.95
Debt to Equity
300.83
Beta
-0.16
Per Share Data
EPS (TTM)
₹-7.50
Book Value per Share
₹15.25
Revenue per Share
₹60.97
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| VINEETLAB | 796.1M | 316.25 | 2.62 | -137.85% | -18.10% | 300.83 |
| Navin Fluorine | 322.4B | 57.84 | 8.89 | 10.99% | 17.74% | 32.68 |
| Deepak Nitrite | 230.5B | 43.19 | 4.18 | 12.85% | 6.71% | 22.41 |
| Ghcl | 46.2B | 9.54 | 1.33 | 17.89% | 16.60% | 2.66 |
| Styrenix Performance | 41.0B | 24.75 | 3.29 | 20.14% | 4.66% | 44.08 |
| Chemplast Sanmar | 38.6B | 210.40 | 2.02 | -5.34% | -7.01% | 96.73 |
Financial data is updated regularly. All figures are in the company's reporting currency.





